Leadership Overview
MiMedx Group has 5 executives leading key functions including strategy, finance, operations, medical affairs, and legal.
Driven by innovation, MiMedx Group is dedicated to developing and marketing regenerative biologics that leverage human placental tissue allografts, aiming to significantly improve patient outcomes across diverse healthcare sectors.
Driven by innovation, MiMedx Group is dedicated to developing and marketing regenerative biologics that leverage human placental tissue allografts, aiming to significantly improve patient outcomes across diverse healthcare sectors.
Leadership Roles at MiMedx Group
Joseph Capper - Chief Executive Officer
Joseph Capper, the Chief Executive Officer at MiMedx Group, directs the overarching corporate strategy and vision. Capper guides the company's expansion in regenerative biologics, focusing on patent-protected processes for diverse healthcare applications. Overseeing the development and marketing of human placental tissue allografts, the Chief Executive Officer ensures alignment with market needs and scientific advancement. This leadership role involves driving innovation in biomaterial platform technologies such as AmnioFix and EpiFix. By championing the company's proprietary PURION Process, Joseph Capper enhances the production of allografts for wound care, orthopedics, and other critical medical fields. Ultimately, Capper secures the company's position as a leader in regenerative medicine.
Douglas Rice - Chief Financial Officer
Douglas Rice, the Chief Financial Officer at MiMedx Group, manages all financial operations and strategic fiscal planning. Rice oversees budgeting, forecasting, and financial reporting, ensuring the company's fiscal health and compliance. Directing capital allocation and investment strategies, the Chief Financial Officer supports the company's growth initiatives in regenerative biologics. This role involves managing investor relations and communicating financial performance to stakeholders. By optimizing financial structures, Douglas Rice enables MiMedx Group to invest in research and development for its proprietary processing methodologies. Ultimately, Rice ensures the financial stability required for expanding market reach in wound care, orthopedics, and surgical applications.
William Taylor - President & Chief Operating Officer & Board Member
William Taylor, the President & Chief Operating Officer & Board Member at MiMedx Group, orchestrates daily operations and drives operational efficiency. Taylor oversees the manufacturing and supply chain for regenerative biologics, ensuring the integrity of the PURION Process. Directing cross-functional teams, the President & Chief Operating Officer & Board Member ensures seamless integration of product development and market delivery. This leadership position involves optimizing production of allografts derived from human placental tissue. By managing operational scaling, William Taylor supports the company's expansion into new therapeutic areas like spine and sports medicine. Ultimately, Taylor ensures the reliable delivery of MiMedx Group's innovative biomaterials to healthcare providers globally.
David Mason - Chief Medical Officer
David Mason, the Chief Medical Officer at MiMedx Group, provides critical medical and scientific leadership. Mason guides clinical strategy and oversees the evaluation of regenerative biologics, ensuring efficacy and patient safety. Directing medical affairs, the Chief Medical Officer collaborates with research teams on the application of technologies like AmnioFix and EpiCord. This role involves translating scientific findings into clinical practice for wound care, orthopedics, and surgical applications. By championing evidence-based medicine, David Mason supports the development of new indications for the company's placental tissue allografts. Ultimately, Mason ensures MiMedx Group's products meet the highest medical standards and address unmet clinical needs.
William Hulse - General Counsel & Chief Administrative Officer
William Hulse, the General Counsel & Chief Administrative Officer at MiMedx Group, leads legal affairs and corporate administration. Hulse manages all legal aspects, including intellectual property, regulatory compliance, and corporate governance. Directing administrative functions, the General Counsel & Chief Administrative Officer ensures operational support for the company's biopharmaceutical activities. This role involves safeguarding the company's proprietary processes and patent portfolio. By overseeing legal frameworks, William Hulse supports MiMedx Group's expansion into international markets and its adherence to global healthcare regulations. Ultimately, Hulse provides essential legal and administrative counsel to drive strategic objectives.
Explore Leadership Teams in Manufacturing
Johnson & Johnson MedTech is a medical technology company founded in 1969 that develops and manufactures advanced healthcare solutions and medical devices. The company specializes in creating purposeful technology for medical interventions across various healthcare fields. With global operations spanning North America, Europe, Asia, and other regions, Johnson & Johnson MedTech combines healthcare expertise with innovative engineering to transform medical intervention capabilities. The company offers B2B solutions and maintains a mobile app platform to support its medical technology services.
Company Leadership RJ
SJ
RB
OB
Founded in 1989 and headquartered in Princeton, New Jersey, Integra LifeSciences is a medical technology company that develops and manufactures surgical instruments, neurosurgical devices, and advanced wound care and tissue repair products. Through its Codman Specialty Surgical and Tissue Technologies segments, the company serves neurosurgeons, neurocritical care teams, ENT specialists, plastic and reconstructive surgeons, and general surgeons. Its portfolio includes neurosurgical tools and systems such as dural repair products, cerebrospinal fluid management devices, intracranial monitoring equipment, and cranial stabilization devices, as well as surgical headlamps and general surgical instruments. Integra also provides specialized solutions for acute and chronic wound management, including burns and diabetic foot ulcers, and offers products for soft tissue, bone, nerve, and tendon repair. In ear, nose, and throat care, the company supplies instrumentation, balloon technologies for sinus and eustachian tube dilation, and surgical navigation systems. Sold through direct sales teams and distribution partners to hospitals, surgery centers, and healthcare providers worldwide, Integra LifeSciences positions itself as a comprehensive partner for complex surgical and reconstructive care.
Company Leadership
CS
CV
TM
CooperVision is committed to helping people around the world see better every day. Through scientific and technological innovation, operational excellence and close working relationships with our eye care professional customers, CooperVision has helped improve the vision of millions and become a trusted global leader in the contact lens industry. CooperVision designs and manufactures innovative, high quality contact lenses to meet a remarkably wide range of wearer needs. We conduct extensive ongoing research and development in optical science. And we collaborate closely with eye care professionals, who help us identify the evolving needs of contact lens wearers around the world.
Company Leadership JC
SR
CH
JW
Established in 2001, PartsSource is a multi-vendor supplier of medical replacement parts. The company is headquartered in Aurora, Ohio.
Company Leadership PB
AL
GM
TM
Frequently Asked Questions Regarding MiMedx Group Top Executives and Leadership Team
